Zbigniew K Wszolek Selected Research

Parkinsonian Disorders (Parkinsonism)

1/2022	L-Dopa response, choreic dyskinesia, and dystonia in Perry syndrome.
12/2021	Clinical, pathological and genetic characteristics of Perry disease-new cases and literature review.
12/2020	Association of mitochondrial genomic background with risk of Multiple System Atrophy.
1/2020	Cognitive and behavioral profile of Perry syndrome in two families.
1/2018	Diffuse Lewy body disease manifesting as corticobasal syndrome: A rare form of Lewy body disease.
1/2018	Establishing diagnostic criteria for Perry syndrome.
9/2017	Reduced orexin immunoreactivity in Perry syndrome and multiple system atrophy.
8/2017	Perry Syndrome: A Distinctive Type of TDP-43 Proteinopathy.
1/2017	Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies.
8/2016	TREM2 p.R47H substitution is not associated with dementia with Lewy bodies.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zbigniew K Wszolek Research Topics

Disease

69	Parkinson Disease (Parkinson's Disease) 06/2022 - 02/2002
31	Parkinsonian Disorders (Parkinsonism) 01/2022 - 08/2002
21	Frontotemporal Dementia (Semantic Dementia) 01/2022 - 05/2007
19	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2022 - 02/2002
15	Dementia (Dementias) 11/2021 - 12/2008
12	Alzheimer Disease (Alzheimer's Disease) 11/2021 - 01/2008
11	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2022 - 06/2008
11	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 03/2015 - 09/2008
10	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 10/2021 - 09/2006
9	Tremor (Tremors) 01/2022 - 02/2002
9	Lewy Body Disease (Lewy Body Dementia) 01/2022 - 01/2010
9	Multiple System Atrophy 01/2021 - 01/2010
8	Essential Tremor (Essential Tremors) 12/2016 - 09/2009
6	Cognitive Dysfunction 01/2021 - 11/2009
5	Machado-Joseph Disease (Spinocerebellar Ataxia Type 3) 01/2022 - 10/2020
5	Leukoencephalopathies 01/2022 - 12/2020
5	Synucleinopathies 11/2021 - 01/2014
4	Dystonia (Limb Dystonia) 01/2022 - 10/2009
4	Ataxia (Dyssynergia) 01/2021 - 05/2011
4	Corticobasal Degeneration 12/2020 - 08/2012
4	Mitochondrial Diseases (Mitochondrial Disease) 11/2014 - 03/2012
3	Disease Progression 01/2022 - 07/2014
3	Dyskinesias (Dyskinesia) 01/2022 - 10/2005
3	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2021 - 01/2002
3	Atrophy 01/2019 - 03/2012
3	Tauopathies 10/2018 - 01/2016
3	Weight Loss (Weight Reduction) 01/2018 - 08/2017
3	Motor Neuron Disease (Primary Lateral Sclerosis) 09/2017 - 01/2010
3	Sarcoma (Soft Tissue Sarcoma) 09/2014 - 11/2011
2	Movement Disorders (Movement Disorder) 01/2021 - 10/2016
2	COVID-19 01/2021 - 01/2020
2	Disease Susceptibility (Diathesis) 01/2021 - 10/2013
2	Hallucinations (Hallucination) 01/2018 - 08/2016
2	Hypoventilation 09/2017 - 08/2017
2	Malnutrition (Nutritional Deficiencies) 02/2014 - 05/2011
2	Hereditary Diffuse Leukoencephalopathy with Spheroids 08/2012 - 12/2011
2	Dysarthria (Spastic Dysarthria) 05/2011 - 11/2009
2	Pallidopontonigral Degeneration 07/2010 - 05/2007
2	Hypokinesia (Bradykinesia) 05/2003 - 02/2002
1	Cerebellar Ataxia (Dysmetria) 01/2022
1	Pick Disease of the Brain (Pick's Disease) 01/2021
1	Brain Injuries (Brain Injury) 11/2020
1	Stroke (Strokes) 11/2020

Drug/Important Bio-Agent (IBA)

25	Phosphotransferases (Kinase)IBA 01/2021 - 04/2005
24	Leucine (L-Leucine)FDA Link 01/2021 - 04/2005
18	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2022 - 08/2007
17	Levodopa (L Dopa)FDA LinkGeneric 01/2022 - 01/2003
16	SynucleinsIBA 01/2022 - 08/2010
13	Proteins (Proteins, Gene)FDA Link 10/2020 - 09/2008
12	ProgranulinsIBA 01/2020 - 08/2007
10	Apolipoproteins E (ApoE)IBA 11/2021 - 09/2006
10	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2019 - 09/2008
8	UbiquitinIBA 01/2021 - 09/2007
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 05/2007
7	alpha-SynucleinIBA 12/2020 - 02/2009
5	polyglutamineIBA 01/2022 - 01/2002
5	Amyloid (Amyloid Fibrils)IBA 10/2018 - 01/2013
4	Macrophage Colony-Stimulating FactorIBA 01/2022 - 12/2011
4	ApolipoproteinsIBA 10/2018 - 09/2006
4	Dopamine (Intropin)FDA LinkGeneric 01/2017 - 02/2002
3	Mitochondrial DNA (mtDNA)IBA 01/2022 - 01/2020
3	Ataxin-3IBA 01/2022 - 10/2020
3	Apolipoprotein E4IBA 11/2021 - 11/2020
3	Glucosylceramidase (Glucocerebrosidase)IBA 01/2020 - 08/2010
3	Ataxin-2IBA 10/2014 - 01/2002
3	Dihydroxyphenylalanine (Dopa)IBA 07/2011 - 08/2002
3	Pharmaceutical PreparationsIBA 05/2011 - 12/2006
2	IGF-I-IGFBP-3 complex FDA Link 01/2022 - 03/2014
2	Serine (L-Serine)FDA Link 01/2021 - 01/2018
2	Biological ProductsIBA 10/2020 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 09/2013
2	Cholinergic Agents (Cholinergics)IBA 01/2018 - 01/2018
2	AcetylcholinesteraseIBA 01/2018 - 07/2010
2	Protein Isoforms (Isoforms)IBA 01/2018 - 01/2017
2	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2017 - 12/2010
2	PTEN-induced putative kinaseIBA 01/2017 - 11/2014
2	tau Proteins (tau Protein)IBA 01/2016 - 08/2015
2	levodopa drug combination carbidopa (Nakom)FDA LinkGeneric 01/2016 - 01/2016
2	Amino Acids FDA Link 08/2015 - 01/2013
2	ChromatinIBA 09/2014 - 11/2011
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2014 - 01/2014
2	Dopamine Agonists (Dopamine Agonist)IBA 12/2006 - 01/2003
1	Cathepsin BIBA 06/2022
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 04/2022
1	GranulinsIBA 01/2022
1	Poly Adenosine Diphosphate RiboseIBA 01/2022
1	tilavonemabIBA 10/2021
1	Apolipoprotein E3IBA 09/2021
1	remdesivirIBA 01/2021
1	tributyl phosphate (TBP)IBA 01/2021
1	Alkaline PhosphataseIBA 01/2021
1	NucleotidesIBA 01/2021
1	TATA-Box Binding Protein (TATA-Binding Protein)IBA 01/2021
1	Tumor Necrosis Factor Ligand Superfamily Member 14IBA 01/2021
1	Interferon-gamma (Interferon, gamma)IBA 12/2020
1	Amantadine (Aman)FDA LinkGeneric 01/2020

Therapy/Procedure

14	Therapeutics 01/2022 - 03/2003
1	Aftercare (After-Treatment) 10/2021
1	Ligation 01/2021
1	Hematopoietic Stem Cell Transplantation 12/2020